166533-36-4

166533-36-4 - Names and Identifiers

Name	N8-Desethylcarbamoyl-N1-ethylcarbamoyl Cabergoline
Synonyms	Cabergoline impurity B Cabergoline Impurity 4 Cabergoline EP Impurity B N8-Desethylcarbamoyl-N1-ethylcarbamoyl Cabergoline (6aR,9R,10aR)-9-N-[3-(dimethylamino)propyl]-4-N-ethyl-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-4,9-dicarboxamide (6aR,9R,10aR)-N9-[3-(Dimethylamino)propyl]-N4-ethyl-7-(prop-2-enyl)-6a,7,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-4,9(6H)-dicarboxamide
CAS	166533-36-4

166533-36-4 - Physico-chemical Properties

Molecular Formula	C26H37N5O2
Molar Mass	451.60428
Storage Condition	2-8°C

166533-36-4 - Introduction

N8-Desethylcarbamoyl-N1-ethylcarbamoyl Cabergoline (n8-desacetamido-formyl-n1-acetamido Cabergoline) is a compound which is a derivative of Cabergoline (Cabergoline). This compound has the following properties:

1. Nature: N8-Desethylcarbamoyl-N1-ethylcarbamoyl Cabergoline is a white solid, stable at room temperature. It has a high solubility, better solubility in some organic solvents.

2. Use: N8-Desethylcarbamoyl-N1-ethylcarbamoyl Cabergoline is usually used as a drug intermediate. It is widely used in the pharmaceutical industry, mainly for the synthesis of anti-Parkinson drugs and anti-hyperprolactinemia drugs.

3. Preparation method: N8-Desethylcarbamoyl-N1-ethylcarbamoyl Cabergoline can be synthesized by chemical synthesis method. In general, it is synthesized by formylation of Cabergoline with acetamide and desacetamido.

4. Safety Information: Relatively little data is available on the safety and toxicity of N8-Desethylcarbamoyl-N1-ethylcarbamoyl. When using or handling, it is necessary to follow appropriate laboratory practices and safe operating methods to ensure safety. Wear appropriate protective equipment such as goggles and gloves when using the compound. In addition, the compound should be stored and handled properly to avoid reaction with other chemicals. If necessary, it is recommended that the compound be used and handled under appropriate professional guidance.

Last Update：2024-04-09 20:52:54